NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 50 filers reported holding NUVALENT INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $384,904 | -83.9% | 8,380 | -85.3% | 0.00% | -100.0% |
| Q2 2023 | $2,397,316 | -61.4% | 56,916 | -76.1% | 0.00% | -75.0% |
| Q1 2023 | $6,215,353 | -14.2% | 237,954 | -2.2% | 0.00% | -20.0% |
| Q4 2022 | $7,244,033 | -6.6% | 243,415 | -69.5% | 0.01% | -16.7% |
| Q3 2022 | $7,752,745 | -54.2% | 797,312 | -36.1% | 0.01% | -50.0% |
| Q2 2022 | $16,926,000 | -8.9% | 1,247,165 | -6.7% | 0.01% | +33.3% |
| Q1 2022 | $18,577,000 | -28.9% | 1,337,425 | -5.7% | 0.01% | -18.2% |
| Q4 2021 | $26,144,000 | -13.4% | 1,418,047 | -0.7% | 0.01% | -15.4% |
| Q3 2021 | $30,174,000 | – | 1,427,976 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,991,024 | $918,987,373 | 20.25% |
| Bain Capital Life Sciences Investors, LLC | 3,577,267 | $164,446,964 | 18.39% |
| Fairmount Funds Management LLC | 2,451,819 | $112,710,119 | 13.56% |
| Paradigm Biocapital Advisors LP | 1,638,147 | $75,305,618 | 5.11% |
| COMMODORE CAPITAL LP | 828,778 | $38,098,925 | 4.45% |
| Perceptive Advisors | 2,463,451 | $113,244,842 | 3.78% |
| Boxer Capital, LLC | 1,210,192 | $55,632,526 | 2.96% |
| Tri Locum Partners LP | 113,528 | $5,218,882 | 1.67% |
| Ikarian Capital, LLC | 278,034 | $12,781,224 | 1.54% |
| Ikarian Capital, LLC | 2,395 | $11,009,815 | 1.32% |